Fluocinolone acetonide ( FAc) 0.2 mg intravitreal implant in the treatment of diabetic macular edema (DME)

被引：0
|
作者：
Liu, John [1 ]
Coney, Joseph [2 ]
Schartman, Jerome [2 ]
Miller, David G. [2 ]
Zegarra, Hernando [2 ]
Rao, Llewelyn [2 ]
机构：
[1] Case Western Reserve Univ, Ophthalmol, Clevleand, OH USA
[2] Retina Associates Cleveland Inc, Cleveland, OH USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2018年 / 59卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4816
引用
收藏
页数：1
相关论文
共 50 条
  • [41] One-Year Follow Up Results of Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema (DME) in Highly Treated Eyes
    Dhawlikar, Nisha
    Shah, Sumit P.
    Yarian, David L.
    Prenner, Jonathan
    Friedman, Eric S.
    Wheatley, H. Matthew
    Fine, Howard F.
    Mantopoulos, Dimosthenis
    Roth, Daniel B.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [42] Progression of diabetic retinopathy in patients treated with 0.2 μg/day fluocinolone acetonide (FAc) implants for diabetic macular edema (DME): a fellow eye controlled analysis
    Iezzi, Raymond
    Kapik, Barry
    Green, Ken E.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [43] Real-life visual and anatomical outcomes with fluocinolone acetonide (FAc) and cumulative cost of treatment in the treatment of chronic diabetic macular edema (DME)
    Goncalves, Rita
    Coelho, Pedro
    Teixeira, Carla
    Carvalho, Rui
    Vieira, Bruna
    Maio, Tiago
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [44] Retinal Morpho-Functional Changes Following 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Chronic Diabetic Macular Edema
    Angelo Maria Minnella
    Stefano Maria Picardi
    Martina Maceroni
    Francesca Albanesi
    Elisa De Siena
    Giorgio Placidi
    Carmela Grazia Caputo
    Umberto De Vico
    Stanislao Rizzo
    Benedetto Falsini
    Advances in Therapy, 2021, 38 : 3143 - 3153
  • [45] The 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema (vol 248, pg 16, 2023)
    Merrill, Pauline T.
    Holekamp, Nancy
    Roth, Daniel
    Kasper, Jonathan
    Grigorian, Ruben
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2023, 252 : 336 - 336
  • [46] Injectable 0.19-mg fluocinolone acetonide intravitreal implant for the treatment of non-infectious uveitic macular edema
    Lea F. Weber
    Stefanie Marx
    Gerd U. Auffarth
    Alexander F. Scheuerle
    Tamer Tandogan
    Christian Mayer
    Ramin Khoramnia
    Journal of Ophthalmic Inflammation and Infection, 9
  • [47] Injectable 0.19-mg fluocinolone acetonide intravitreal implant for the treatment of non-infectious uveitic macular edema
    Weber, Lea F.
    Marx, Stefanie
    Auffarth, Gerd U.
    Scheuerle, Alexander F.
    Tandogan, Tamer
    Mayer, Christian
    Khoramnia, Ramin
    JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION, 2019, 9 (1)
  • [48] Patterns of retinal thickness prior to and following treatment with fluocinolone acetonide 190 μg intravitreal implant for diabetic macular edema
    Currie, Craig J.
    Holden, Sarah E.
    Owens, David R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 : 33 - 43
  • [49] Retinal Morpho-Functional Changes Following 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Chronic Diabetic Macular Edema
    Minnella, Angelo Maria
    Picardi, Stefano Maria
    Maceroni, Martina
    Albanesi, Francesca
    De Siena, Elisa
    Placidi, Giorgio
    Caputo, Carmela Grazia
    De Vico, Umberto
    Rizzo, Stanislao
    Falsini, Benedetto
    ADVANCES IN THERAPY, 2021, 38 (06) : 3143 - 3153
  • [50] Changes in the cup-to-disc ratio in patients with diabetic macular edema (DME) treated with fluocinolone acetonide (FAc) implants
    Parrish, Richard K.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
12345